» Articles » PMID: 39730911

Genome-scale Modeling Identifies Dynamic Metabolic Vulnerabilities During the Epithelial to Mesenchymal Transition

Overview
Journal Commun Biol
Specialty Biology
Date 2024 Dec 28
PMID 39730911
Authors
Affiliations
Soon will be listed here.
Abstract

Epithelial-to-mesenchymal transition (EMT) is a conserved cellular process critical for embryogenesis, wound healing, and cancer metastasis. During EMT, cells undergo large-scale metabolic reprogramming that supports multiple functional phenotypes including migration, invasion, survival, chemo-resistance and stemness. However, the extent of metabolic network rewiring during EMT is unclear. In this work, using genome-scale metabolic modeling, we perform a meta-analysis of time-course transcriptomics, time-course proteomics, and single-cell transcriptomics EMT datasets from cell culture models stimulated with TGF-β. We uncovered temporal metabolic dependencies in glycolysis and glutamine metabolism, and experimentally validated isoform-specific dependency on Enolase3 for cell survival during EMT. We derived a prioritized list of metabolic dependencies based on model predictions, literature mining, and CRISPR-Cas9 essentiality screens. Notably, enolase and triose phosphate isomerase reaction fluxes significantly correlate with survival of lung adenocarcinoma patients. Our study illustrates how integration of heterogeneous datasets using a mechanistic computational model can uncover temporal and cell-state-specific metabolic dependencies.

Citing Articles

Metabolic Objectives and Trade-Offs: Inference and Applications.

Lin D, Khattar S, Chandrasekaran S Metabolites. 2025; 15(2).

PMID: 39997726 PMC: 11857637. DOI: 10.3390/metabo15020101.

References
1.
Pacini C, Dempster J, Boyle I, Goncalves E, Najgebauer H, Karakoc E . Integrated cross-study datasets of genetic dependencies in cancer. Nat Commun. 2021; 12(1):1661. PMC: 7955067. DOI: 10.1038/s41467-021-21898-7. View

2.
Shen F, Boccuto L, Pauly R, Srikanth S, Chandrasekaran S . Genome-scale network model of metabolism and histone acetylation reveals metabolic dependencies of histone deacetylase inhibitors. Genome Biol. 2019; 20(1):49. PMC: 6397465. DOI: 10.1186/s13059-019-1661-z. View

3.
Lin Y, Satani N, Hammoudi N, Yan V, Barekatain Y, Khadka S . Author Correction: An enolase inhibitor for the targeted treatment of ENO1-deleted cancers. Nat Metab. 2020; 3(1):122. DOI: 10.1038/s42255-020-00335-x. View

4.
Bergers G, Fendt S . The metabolism of cancer cells during metastasis. Nat Rev Cancer. 2021; 21(3):162-180. PMC: 8733955. DOI: 10.1038/s41568-020-00320-2. View

5.
Zur H, Ruppin E, Shlomi T . iMAT: an integrative metabolic analysis tool. Bioinformatics. 2010; 26(24):3140-2. DOI: 10.1093/bioinformatics/btq602. View